BSE filing, NSE: ELCIDIN. Summary written from the filing by ALFA Finder's alert engine.
Elcid Investments Ltd: key numbers
- Share price
- ₹98,400.00
- Market cap
- ₹1,968 Cr
- Revenue (annual)
- ₹134.0 Cr
- Net profit (annual)
- ₹108.5 Cr
- P/E (TTM)
- 20.6×Sector 45.0×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Elcid Investments Ltd
All →Elcid Investments Board Meeting Date
Elcid Investments Limited intimated a board meeting on 3 November 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. The trading window closes from 25 September to 5 November 2026.
Elcid Investments Other Announcement
EL CID Investments Ltd has filed its quarterly shareholding pattern for the period ending September 30, 2026, as required under SEBI regulations.
Elcid Investments Q1 FY27 Results: Net Profit ₹57.6 Cr, Down 18.4% YoY
Elcid Investments Ltd reported revenue from operations of ₹73.4 Cr (-20.2% YoY) and net profit of ₹57.6 Cr (-18.4% YoY) for Q1 FY27.
- Key figure
- Net profit ₹57.6 Cr · -18.4% YoY
Elcid Investments Management Change
The company has re-appointed Ms. Amrita Vakil as Executive Director and Mr. Kartikeya Kaji as Non-Executive Independent Director, effective as per AGM approvals.
Elcid Investments Annual General Meeting
Elcid Investments held its 45th Annual General Meeting on July 31, 2026. Shareholders approved the company's annual accounts and a dividend of ₹25 per equity share.
Elcid Investments Annual Report
Elcid Investments Ltd submitted its FY 2025‑26 Annual Report and notice convening the 45th AGM. The AGM will be held on 31 July 2026 via video conference.
Other board meeting date announcements
All →Innocorp Board Meeting Date
Innocorp Ltd will hold a board meeting on 05 November 2026 to consider unaudited results for the quarter and half year ended 30 September 2026. This is an advance intimation with no results figures attached.
Prism Medico and Pharmacy Board Meeting Date
Prism Medico and Pharmacy will hold a board meeting on November 5, 2026 to consider unaudited standalone half-yearly financial results for the period ended September 2026. The trading window closes from October 1 until November 7, 2026.
Fredun Pharmaceuticals Board Meeting Date
Fredun Pharmaceuticals will hold a board meeting on 05 November 2026 to consider half-year results. Trading window stays closed until 48 hours after results.
Capricorn Systems Global Solutions Board Meeting Date
Capricorn Systems Global Solutions Ltd notified BSE of a board meeting on 07 November 2026 to consider unaudited financial results for the quarter and half-year ended 30 September 2026. The filing is an advance notice with no results figures attached.
Ganesh Green Bharat Board Meeting Date
Ganesh Green Bharat will hold a board meeting on 5 November 2026 to consider unaudited half-yearly results. Trading window stays closed until 10 November 2026.
Yogi Board Meeting Date
YOGI Ltd schedules a board meeting on 5 November 2026 for Q2 results and a director regularisation. Trading window closes 1 October to 7 November 2026.